Another notable observation is that ADHD patients with a CNTN4 mutation phenotype tend to be more severe, with a higher prevalence of emotional dysregulation and demonstrate enriched response to fasoracetam. The gene discussed is CNTN4; the disease is attention deficit-hyperactivity disorder.